NIH R01 · 2024
In the last 30 years, there has been no significant improvement in rates of venous thromboembolism (VTE). These blood clots develop in the limbs and can travel to the lungs and form pulmonary emboli, which are the most common cause of preventable deaths in the hospital. Currently available tools for predicting and preventing hospital-acquired VTE (HA-VTE) were developed without sufficient input from frontline clinicians, add to clinician workload, are too cumbersome to implement in daily clinical practice, exhibit poor-to-fair prediction accuracy, and do not consider the risk of bleeding complications. Importantly, use of these tools has not been shown to improve patient outcomes. A…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.